| Revision as of 15:15, 14 December 2024 editVortexjourney754 (talk | contribs)158 editsmNo edit summaryTag: Visual edit← Previous edit | Revision as of 00:06, 16 December 2024 edit undoVortexjourney754 (talk | contribs)158 editsmNo edit summaryTag: Visual editNext edit → | ||
| Line 4: | Line 4: | ||
| }} | }} | ||
| {{Infobox company | {{Infobox company | ||
| | name = | |||
| | type = ] | | type = ] | ||
| | industry = ] | | industry = ] | ||
| Line 14: | Line 15: | ||
| }} | }} | ||
| '''Bias Capital''' is an American ] that invests in both early-stage ] and established ]. | '''Bias Capital, LLC''' (commonly known as '''Bias Capital''') is an American ] that invests in both early-stage ] and established ]. | ||
| The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process. | The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process. | ||
Revision as of 00:06, 16 December 2024
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
| Company type | Private |
|---|---|
| Industry | Venture capital |
| Founded | February 2021; 3 years ago (2021-02) |
| Founder | Maximillian Naza |
| Headquarters | San Francisco, California, U.S. |
| Products | Investments |
| Website | https://bias.capital/ |
Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies.
The firm was established to integrate diversity as a core principle in its investment strategy and operations. Rather than treating diversity as a separate initiative, Bias Capital incorporates it into all aspects of its decision-making process.
The firm aims to build a portfolio that reflects societal diversity by supporting underrepresented founders and fostering inclusive innovation.
Bias Capital operates as the venture capital arm of PasciVite.
Notable Investments
In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.
- "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.